A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
Clinical trial NCT04172987 · COMPLETED
Trial details
- NCT number
- NCT04172987
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2021-02-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.